News Opdivo Plus Chemotherapy Approved for First-Line Treatment of Gastric Cancer By Brian Park, PharmD Publish Date April 16, 2021
News Trodelvy Gets Accelerated Approval for Urothelial Cancer By Brian Park, PharmD Publish Date April 14, 2021
Drugs in the Pipeline Tisotumab Vedotin Under Review for Recurrent or Metastatic Cervical Cancer By Brian Park, PharmD Publish Date April 13, 2021
News FDA Clears AI System to Detect Lesions During Colonoscopy By Diana Ernst, RPh Publish Date April 12, 2021
News FDA Grants Full Approval to Trodelvy for Triple-Negative Breast Cancer By Brian Park, PharmD Publish Date April 8, 2021
News New Dosing Regimen Approved for Erbitux in Colorectal, Head and Neck Cancer By Brian Park, PharmD Publish Date April 7, 2021
News FDA: Complications Up for 2 Brands of Surgical Mesh Used in Breast Reconstruction Publish Date April 5, 2021
News Sarclisa Plus Carfilzomib and Dexamethasone Approved for Relapsed/Refractory Multiple Myeloma By Brian Park, PharmD Publish Date April 2, 2021
News FDA Approves Vyxeos for Secondary Acute Myeloid Leukemia in Pediatric Patients By Brian Park, PharmD Publish Date March 31, 2021
News Abecma Approved for Relapsed/Refractory Multiple Myeloma By Brian Park, PharmD Publish Date March 29, 2021
News FDA-Approved VEGFR Tyrosine Kinase Inhibitors Ranked by Cardiotoxic Potential By Cassandra Pardini, PharmD Publish Date March 25, 2021
News Maintenance Therapy Without Steroids Feasible in Elderly Myeloma Patients Publish Date March 25, 2021